Literature DB >> 22107175

Development and optimization of lyophilized orally disintegrating tablets using factorial design.

Iman Saad Ahmed1, Rehab Nabil Shamma, Ragia Ali Shoukri.   

Abstract

The aim of this study was to evaluate the use of maltodextrin as a sugar-matrix former along with several cellulosic binders in the preparation of freeze-dried orally disintegrating tablets (ODT). The ODT was prepared by freeze-drying an aqueous dispersion of nimesulide (NM) containing maltodextrin and a cellulosic binder. The influence of formulation parameters on the in vitro/in vivo disintegration time and in vitro dissolution of NM from ODTs along with other tablet characteristics was investigated using full factorial design. The optimized ODT contained 5% w/v maltodextrin DE 29, 2% w/v Methocel E15, and 5% w/v NM, disintegrated in less than 10 s and showed more than 70% of NM in ODTs dissolved within 2 min, compared to only 1.52% of NM plain drug and 7.25% of NM in immediate release commercial tablet. Crystalline state evaluation of NM in the optimized ODT was conducted through differential scanning calorimetry, and X-ray powder diffraction. The study suggests that the optimized ODT formulation developed in this work may be an alternative to conventional formulations of NM inconvenient to the patients such as intramuscular or rectal administration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22107175     DOI: 10.3109/10837450.2011.619543

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  2 in total

1.  Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfusion (SPIP) studies and pharmacokinetics in rat.

Authors:  Kishan S Italiya; Arihant K Singh; Deepak Chitkara; Anupama Mittal
Journal:  AAPS PharmSciTech       Date:  2021-03-24       Impact factor: 3.246

2.  A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study.

Authors:  Mahmoud H Teaima; Khaled M Abdel-Haleem; Rewan Osama; Mohamed A El-Nabarawi; Osama S Elnahas
Journal:  Drug Des Devel Ther       Date:  2021-10-07       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.